Xinhao Song
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours.
Journal: Veterinary and comparative oncology
Published: March 16, 2026
The E420K mutation in myosin5 confers field resistance to phenamacril in Fusarium asiaticum.
Journal: Pesticide biochemistry and physiology
Published: April 16, 2025
Enrofloxacin‑silver composite nano-emulsion as a scalable synergetic antibacterial platform for accelerating infected wound healing.
Journal: International journal of pharmaceutics: X
Published: December 13, 2024
New uses of halofuginone to treat cancer.
Journal: Journal of pharmaceutical analysis
Published: May 23, 2024
Enhanced In Vitro Antiviral Activity of Ivermectin-Loaded Nanostructured Lipid Carriers against Porcine Epidemic Diarrhea Virus via Improved Intracellular Delivery.
Journal: Pharmaceutics
Published: March 28, 2024
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.
Journal: Breast cancer research and treatment
Published: February 23, 2024
Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 10, 2023
Optimization of Maduramicin Ammonium-Loaded Nanostructured Lipid Carriers Using Box-Behnken Design for Enhanced Anticoccidial Effect against Eimeria tenella in Broiler Chickens.
Journal: Pharmaceutics
Published: May 12, 2022
Repurposing maduramicin as a novel anticancer and anti-metastasis agent for triple-negative breast cancer as enhanced by nanoemulsion.
Journal: International journal of pharmaceutics
Published: March 30, 2022
Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
Journal: International journal of nanomedicine
Published: December 04, 2021
Maduramicin induces cardiotoxicity via Rac1 signaling-independent methuosis in H9c2 cells.
Journal: Journal of applied toxicology : JAT
Published: February 25, 2021
Last Updated: 09/26/2026